NCT06908772 2025-04-03Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer PatientsShanghai JMT-Bio Inc.Phase 2/3 Not yet recruiting390 enrolled
NCT06525350 2024-07-29A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 2 Not yet recruiting256 enrolled